RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
@crew_buddy @JamesSurowiecki Their effectiveness might decline but they are not rendered moot. Also Moderna seems to be the best against the Delta variant. See this which covers data thru Aug 2021 so includes Delta period: https://t.co/NzfN5LnLy4
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
🤷🏾♂️
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
@CDCgov @WHCOS
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
@HarrySpoelstra @PaulNeirynck Lees ik dit juist dat voor JenJ we eigenlijk aan de 4de prik zouden moeten zitten vermits bescherming maar 1 maand duurt? https://t.co/Ad3qeOXhuz
RT @PabloRichly: Haberse aplicado una vacuna de vector viral en monodosis podría ser considerado un factor de prioridad para recibir un ref…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
@JefMensaert @kyracrispyn Overgewicht verhoogt de kans op hospitalisatie met ongeveer een factor 3 (https://t.co/BehXteyGTH). Vaccins doet de kans op hospitalisatie dalen met ongeveer een factor 1/15 (https://t.co/IqJ0vFOgis). Het lijkt me dan nog altijd l
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
Haberse aplicado una vacuna de vector viral en monodosis podría ser considerado un factor de prioridad para recibir un refuerzo. https://t.co/RlbusrqN0i https://t.co/MsIU43wSl4
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
Enqto isso nos eua o pessoal não só é sommelier de vacina, como acham absurdo deixar qm tomou janssen à deriva. Imagina se lá tivessem usado coronavac.
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
RT @EricTopol: Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after…
Meanwhile we have left the people who got a J&J vaccine stranded with comparatively very low antibody levels 2-6 weeks after dosing, while we've learned such levels are tied to protection https://t.co/kvBoSzBkBd I think that's now ill-considered. https
@georgiyaaa @Covid19Crusher https://t.co/kbPaOBqZRR 93% and 88% effective in preventing hospitalizations
RT @MIKITO_777: モデルナ・ファイザー・J&J(日本未承認)の3種類のワクチンの有効性(入院抑制効果)についてのデータ。 やはり、モデルナが一番高く、ファイザーがそれに匹敵する数値となっています。 mRNAワクチンの優位性を示すデータです。 この2種類のワクチ…
[ ...vaccine effectiveness against COVID-19 HOSPITALIZATION during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%) ] https://t.co/c7qGyOnp3p
CDCの週報によると、今年3月から8月までの期間について、各社のワクチンの入院に対する有効性を「120日迄」と「120日後」に分けて比較すると、モデルナが93%から92%とほとんど低下がみられなかったのに対し、ファイザーは91%から77%と有意に低下したようです。 https://t.co/F0KZQzE3J5 @CDCgovより
CDCの週報によると、今年3月から8月までの期間について、各社のワクチンの入院に対する有効性は、次のとおり分析されたようです。 モデルナ93%>ファイザー88%>J&J71% やはり「良薬は口に苦し」なのでしょうか。 Comparative Effectiveness of Moderna... https://t.co/F0KZQzE3J5 @CDCgovより
RT @miguel78910: Vean que belleza CDC👇🏻 Informe semanal de morbilidad y mortalidad (MMWR) Section Navigation Comparative Effectiveness of…
Vean que belleza CDC👇🏻 Informe semanal de morbilidad y mortalidad (MMWR) Section Navigation Comparative Effectiveness of Moderna, Pfizer-BioNTech, and J&J Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditi
Qué vacuna funciona “mejor” según el @CDCgov? Las 3 son maravillosas, salvarán muchas vidas. Para los morbosos, el top 3 contra hospitalización queda tal que así: 1️⃣Moderna 93% 2️⃣Pfizer 88% 3️⃣Janssen 71% (Datos 🇺🇸 donde NO está aprobada AstraZeneca
コロナ云々以前にCDCの治験者のそもそもの健康状態がヤバいですね・・・。 肥満が50%、糖尿病30%、肺疾患持ち25%、何かしらの心疾患が60% 平均58歳のデータとはいえ普通の健康な人のデータが欲しい🙄 https://t.co/ML9ALHYJ1f https://t.co/mSSlEugfXu
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
It's possible that some of the differences in effectiveness we see between Moderna & Pfizer is an artifact of different geographic regions having different vaccine proportions & virus exposures.
RT @DrJBhattacharya: CDC MMWR: Good protection by Pfizer/Moderna/J&J vs. hospitalization 4+ months after complete vax during delta era. I…
RT @emresidents: On Sept 24, @CDCgov released a report finding that all 3 FDA-approved vaccines have continued to provide “substantial prot…
On Sept 24, @CDCgov released a report finding that all 3 FDA-approved vaccines have continued to provide “substantial protection” against COVID hospitalization over the summer. (More discussion coming soon in the upcoming EMRA MSC Newsletter.) https://t.c
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
メモ📝 ワクチン抗体価 文献 https://t.co/yDIIPJgGgk
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
@TiSwegs @Syloustr @scrowder https://t.co/FBFMYCbwHM It's not impressive
120日以降はファイザーよりモデルナのほうが予防効果が高いとのことだが、いまモデルナアームになってて激しく辛たん https://t.co/MHSJ5Ox47w
RT @RWMaloneMD: Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hosp…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
@AndreaSausS1 @fraugenervt @BAG_OFSP_UFSP Ist das Ihr Ernst? Na von mir aus. Hier eine Auswahl: https://t.co/Qyo8bw9Yee https://t.co/LJPu3xD2Az https://t.co/Qli5NG6gjR
p値<0.001はすげぇなしかし https://t.co/ViCkZrYbBR
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
@SAMURAIDRIVE_Tw 師匠、師匠お気を確かに https://t.co/QcqCku9SSj
Comparative Effectiveness of Moderna... https://t.co/4KeltghjSY @CDCgov
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
A new @CDCgov study shows all 3 #COVID19 vaccines authorized or approved in the U.S. provide strong protection against hospitalization for COVID-19. All of these COVID-19 vaccines meet the @US_FDA standards for effectiveness. https://t.co/I5ZshYKXsT #ThisI
Comparative Effectiveness of Moderna... https://t.co/wPi5scWNhL via @CDCgov
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
Comparative Effectiveness of Moderna... https://t.co/wTgxtcl6KY via @CDCgov #COVID
RT @nicolasberrod: Il est vrai que plusieurs études récentes suggèrent que Moderna conserve une meilleure efficacité sur la durée que Pfize…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @sorezoukun: @jijimedical https://t.co/CyBHHo9rbo "ModernaワクチンとPfizer-BioNTechワクチンのVEの違いは、ModernaワクチンのmRNA含量が高いこと、接種時期の違い、または解析では考慮されなかっ…
RT @nicolasberrod: Il est vrai que plusieurs études récentes suggèrent que Moderna conserve une meilleure efficacité sur la durée que Pfize…
RT @nicolasberrod: Il est vrai que plusieurs études récentes suggèrent que Moderna conserve une meilleure efficacité sur la durée que Pfize…